Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.

MLA

Li, Tian-Hao, et al. “Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.” Frontiers in Oncology, vol. 11, May 2021, pp. 1–14. EBSCOhost, https://doi.org/10.3389/fonc.2021.665192.

APA

Li, T.-H., Qin, C., Zhao, B.-B., Cao, H.-T., Yang, X.-Y., Wang, Y.-Y., Li, Z.-R., Zhou, X.-T., & Wang, W.-B. (2021). Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Oncology, 11, 1–14. https://doi.org/10.3389/fonc.2021.665192

Chicago

Li, Tian-Hao, Cheng Qin, Bang-Bo Zhao, Hong-Tao Cao, Xiao-Ying Yang, Yuan-Yang Wang, Ze-Ru Li, Xing-Tong Zhou, and Wei-Bin Wang. 2021. “Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.” Frontiers in Oncology 11 (May): 1–14. doi:10.3389/fonc.2021.665192.